Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

New World cutaneous leishmaniasis imported into Australia.

Maguire Graeme P.; Bastian, Ivan; Arianayagam, Sobhana; Bryceson, Anthony; Currie, Bart J.
Pathology - Journal of the RCPA: 1998
doi: 10.1080/00313029800169715
Original Article: PDF Only

Summary: A case of cutaneous leishmaniasis in a traveller from Belize, Central America is reported. Leishmaniasis presents rarely in Australia and delays in diagnosis and treatment often occur. A high index of suspicion in a patient who has returned from an endemic region is required. Subsequent confirmation of a diagnosis of cutaneous leishmaniasis is best achieved by demonstration of the organism on skin biopsy, aspiration or smear. The histology is variable and depends on geographic, parasite species and host factors. Speciation of New World disease as either Leishmania braziliensis or Leishmania mexicana is important to determine the risk of later development of mucosal disease, which normally only occurs with L. braziliensis infection, and for optimal treatment. Several different modes of treatment have been suggested, but antimonials, such as sodium stibogluconate, remain the treatment of choice in New World cutaneous leishmaniasis.

(C) 1998 Royal College of Pathologists of Australasia

You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website